Kaba Samer 4
4 · ALIMERA SCIENCES INC · Filed Nov 19, 2019
Insider Transaction Report
Form 4
Kaba Samer
Chief Medical Officer
Transactions
- Award
Common Stock
2019-11-15$4.75/sh+149$708→ 5,367 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.
- [F2]On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split, which is reflected in the amount shown in column 5.